Advertisement

Obg Management Logo Home
   
   
Free CME
Classifieds
Register/Login
Home Page Current Issue Past Issues Supplements Podcasts Information for Authors
                                    
   
About Us
Subscribe Renew
Reprints Permissions
Advertising Information
Links and Resources
Classifieds

Advertisement

May 2004 · Vol. 16, No. 5

Hypothyroidism: Should we screen all pregnant women?

What are the practical implications of recent studies linking maternal thyroid deficiency with impaired growth, adverse neurologic outcomes, and fetal death?


SHRAGA  BLAZER,  MD; ETAN  Z.  ZIMMER,  MD

Dr. Blazer is director, neonatal unit, and Dr. Zimmer is director, obstetrics unit, Rambam Medical Center and Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel.

Emerging research indicates that thyroid hormones play a key role in fetal brain development, and asymptomatic hypothyroidism during pregnancy may have an adverse effect on fetal growth and neurologic development. Findings published in the past year call our attention to the importance of identifying and adequately treating thyroid-deficient gravidas:

But given the paucity of data on how maternal hypothyroidism affects the offspring, is universal screening justified? We review the evidence to date, present the current positions of 3 organizations, and offer recommendations for current clinical practice.

Sign in now to read more...

Back to top


Advertisement



Advertisement1


XMLRSS callout
 

Advertisement